Find clinical trials for Alzheimer's Disease in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Warszawa, Mazowieckie, POL:
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...
Phase 2
Warsaw, Poland and 37 other locations
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Sochaczew, Poland and 270 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Warsaw, Poland and 90 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Warsaw, Poland and 103 other locations
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...
Phase 3
Warsaw, Poland and 185 other locations
capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...
Phase 3
Sochaczew, Poland and 240 other locations
This clinical trial is recruiting people who either are at risk of AD - have build-up of beta-amyloid, but have no clinical symptoms, or with a diagn...
Phase 2
Warsaw, Poland and 48 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Warsaw, Poland and 199 other locations
In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...
Phase 2
Warszawa, Poland and 137 other locations
The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The stu...
Phase 3
Warsaw, Poland and 143 other locations
Clinical trials
Research sites
Resources
Legal